IBB
Equity
iShares Biotechnology ETF
- NAV as ofOct 29, 2026
- $217.9952 WK: 156.06 - 217.99
- 1 Day NAV Change as ofOct 29, 2026
- Increase $
1.70(0.79%)
- NAV Total Return as ofOct 28, 2026
- YTD: Increase
28.25%
- 30 Day SEC Yield as ofSep 30, 2026
- -0.15%
- 12m Trailing Yield as ofSep 30, 2026
- 0.16%
- Expense Ratio:Fees as stated in the prospectus
- 0.44%
- Morningstar Rating
- 3 stars
- Morningstar Medalist Rating
- NAV as ofOct 29, 2026
- $217.9952 WK: 156.06 - 217.99
- 1 Day NAV Change as ofOct 29, 2026
- Increase $
1.70(0.79%)
- NAV Total Return as ofOct 28, 2026
- YTD: Increase
28.25%
- 30 Day SEC Yield as ofSep 30, 2026
- -0.15%
- 12m Trailing Yield as ofSep 30, 2026
- 0.16%
- Expense Ratio:Fees as stated in the prospectus
- 0.44%
- Morningstar Rating
- 3 stars
- Morningstar Medalist Rating
The iShares Biotechnology ETF seeks to track an index that includes U.S.-listed equities in the biotechnology sector. The fund offers a way to express a focused view on companies engaged in the research and development of therapeutic treatments.
Key Facts
Net Assets of Fund
Closing Price
Daily Volume
Exchange
NASDAQ
Benchmark Index
NYSE Biotechnology Index
Investment Style
Index
Distribution Frequency
Quarterly
CUSIP
464287556
30 Day Avg. Volume
1,697,797.00
as of Oct 28, 2026
Fund Launch Date
Feb 05, 2001
Asset Class
Equity
Bloomberg Index Ticker
ICEBIOT
Shares Outstanding
52,950,000
as of Oct 29, 2026
Premium/Discount